
Xolair Rival Aims for Food Allergy Dosing of Every 2 to 3 Months
A San Francisco-based biotech company is developing a new blocker of the IgE allergy antibody for treating food allergies. Rapt Therapeutics says that, if it proves successful, this therapy will only require an injectable dose every two or three months. A …